Literature DB >> 10326541

Heterozygote advantage of the MTHFR gene in patients with neural-tube defect and their relatives.

L R Weitkamp, D C Tackels, A G Hunter, L B Holmes, C E Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10326541     DOI： 10.1016/s0140-6736(05)61119-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Genetic thromobophilia in pregnancy: a case-control study among North Indian women.

Authors:  Lovejeet Kaur; Manju Puri; Shweta Kaushik; Mohinder Pal Sachdeva; Shubha Sagar Trivedi; Kallur Nava Saraswathy
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

2.  A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group.

Authors:  Lawrence C Brody; Mary Conley; Christopher Cox; Peadar N Kirke; Mary P McKeever; James L Mills; Anne M Molloy; Valerie B O'Leary; Anne Parle-McDermott; John M Scott; Deborah A Swanson
Journal:  Am J Hum Genet       Date:  2002-10-16       Impact factor: 11.025

3.  Folate supplementation, MTHFR gene polymorphism and neural tube defects: a community based case control study in North India.

Authors:  Roumi Deb; Jyoti Arora; Sanjenbam Yaiphaba Meitei; Sangeeta Gupta; Vanita Verma; Kallur Nava Saraswathy; Sunil Saran; Aloke Kumar Kalla
Journal:  Metab Brain Dis       Date:  2011-07-27       Impact factor: 3.584

Review 4.  Primary prevention of neural-tube defects and some other major congenital abnormalities: recommendations for the appropriate use of folic acid during pregnancy.

Authors:  A E Czeizel
Journal:  Paediatr Drugs       Date:  2000 Nov-Dec       Impact factor: 3.022

5.  The methylenetethrahydrofolate reductase (MTHFR) C677T polymorphism and male infertility in Italy.

Authors:  L Stuppia; V Gatta; O Scarciolla; A Colosimo; P Guanciali-Franchi; G Calabrese; G Palka
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

6.  Heterozygote advantage of methylenetetrahydrofolate reductase polymorphisms on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy.

Authors:  Xiaoying Li; Minhua Shao; Shiming Wang; Xueying Zhao; Hongyan Chen; Ji Qian; Xiao Song; Jiucun Wang; Li Jin; Junjie Wu; Qiang Li; Chunxue Bai; Baohui Han; Zhiqiang Gao; Daru Lu
Journal:  Tumour Biol       Date:  2014-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.